Literature DB >> 12200142

Interaction of oncogenic papillomavirus E6 proteins with fibulin-1.

Minjie Du1, Xueli Fan, Eva Hong, Jason J Chen.   

Abstract

Human papillomavirus (HPV) infection is the primary risk factor for the development of cervical cancer. The papillomavirus E6 gene is essential for virus-induced cellular transformation and the viral life cycle. Important insight into the mechanism of E6 function came from the discovery that cancer-related HPV E6 proteins promote the degradation of the tumor suppressor p53. However, mounting evidence indicates that interaction with p53 does not mediate all E6 activities. To explore the p53-independent functions of E6, we performed a yeast two-hybrid screen and identified fibulin-1 as an E6 binding protein. Fibulin-1 is a calcium-binding plasma and extracellular matrix protein that has been implicated in cellular transformation and tumor invasion. The interaction between E6 and fibulin-1 was demonstrated by both in vitro and in vivo assays. Fibulin-1 is associated specifically with cancer-related HPV E6s and the transforming bovine papillomavirus type 1 E6. Significantly, overexpression of fibulin-1 specifically inhibited E6-mediated transformation. These results suggest that fibulin-1 plays an important role in the biological activities of E6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200142     DOI: 10.1016/s0006-291x(02)02041-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Fibulins: physiological and disease perspectives.

Authors:  W Scott Argraves; Lisa M Greene; Marion A Cooley; William M Gallagher
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

Review 2.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 3.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

4.  1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Authors:  Yves Nominé; Sebastian Charbonnier; Laurent Miguet; Noelle Potier; Alain Van Dorsselaer; R Andrew Atkinson; Gilles Travé; Bruno Kieffer
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

5.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

6.  The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity.

Authors:  Maria Filippova; Melyssa M Johnson; Marnelli Bautista; Valery Filippov; Nadja Fodor; Sandy S Tungteakkhun; Kadia Williams; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

Review 8.  Molecular mechanisms of human papillomavirus-induced carcinogenesis.

Authors:  Michaël Lehoux; Claudia M D'Abramo; Jacques Archambault
Journal:  Public Health Genomics       Date:  2009-08-11       Impact factor: 2.000

9.  Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.

Authors:  Y Y Cheng; H Jin; X Liu; J M T Siu; Y P Wong; E K O Ng; J Yu; W-K Leung; J J Y Sung; F K L Chan
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.